InvestorsHub Logo
Followers 1
Posts 88
Boards Moderated 0
Alias Born 04/24/2011

Re: None

Sunday, 08/18/2013 11:31:42 AM

Sunday, August 18, 2013 11:31:42 AM

Post# of 426264
Just an opinion (a "guess") from another dumb retail investor:
Given the fact that AMRN was speculatively raised to heights of 19 pps when Marine results were announced - AND NOTHING MORE SUBSTANTIAL - AND THAT NOW WE HAVE (1)positive results for Marine and Anchor; (2)very strong patent protections; (3)marketing of Vascepa for Marine with steady growth of new and refill scripts; (4)VERY high probability of AdCom approval; (5) VERY high likelihood of PDUFA approval; (6)ReduceIt moving along well and highly likely to show excellent results;(7)likelihood of VERY SIGNIFICANT increases in scripts after Anchor approval (taking market share from Lovaza from current off-label use of the latter);(8)likelihood of increased advertising of benefits of Vascepa as they are able to bring more information both to MDs and general public; (9) increasing bullish commentary and feeling among the investor population; and (10) shorts covering - with possible short squeeze.... I think that PPS will be as follows (the guessing part of my comments)
1. At AdCom $ 8 - 10
2. At PDUFA $ 11-15
3. Early 2014 $ 18-20
4. Buy Out $ $25-30

Obviously just guesses (but I think good ones). Any thoughts and comments? zbd
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News